March 24, 2022
CytoImmune is Developing a Suite of Novel Engineered Natural Killer Cell Therapeutics for the Treatment of Patients with Cancer The Company is Opening a New Good […]
March 18, 2022
Data to be presented during late breaker poster sessions at 2022 AACR Annual Meeting March 08, 2022 05:50 PM Eastern Standard Time – MONROVIA, Calif.–(BUSINESS WIRE)–CytoImmune […]
January 25, 2022
January 18, 2022
December 14, 2021
November 10, 2021
October 17, 2021
July 16, 2021
June 15, 2021